2-methoxyestradiol has been researched along with Left Ventricular Hypertrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdelhamid, G; Dyck, JRB; El-Kadi, AOS; Fahlman, RP; Levasseur, J; Maayah, ZH; Siraki, AG; Siva Piragasam, R | 1 |
Bastacky, SI; Jackson, EK; Salah, E; Tofovic, SP | 1 |
2 other study(ies) available for 2-methoxyestradiol and Left Ventricular Hypertrophy
Article | Year |
---|---|
2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy.
Topics: 2-Methoxyestradiol; Animals; Cell Line; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Hypertrophy, Left Ventricular; Male; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NF-kappa B; Protective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
Topics: 2-Methoxyestradiol; Angiotensin II; Animals; Blood Pressure; Fibrosis; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Isoproterenol; Kidney; Kidney Diseases; Male; Rats, Sprague-Dawley; Renin-Angiotensin System; Vascular Remodeling; Ventricular Function, Left; Ventricular Remodeling | 2019 |